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in Managing Settlements
FRANCIS E. McGovERN*
In pushing the envelope of dispute system design, we have focused
primarily on successes and productive innovation. We have neglected to
concentrate as well on the less successful and less productive outcomes of
designing dispute systems. One of the most fruitful approaches to second-
generation design of dispute systems can be to focus on failure mode
analysis. Second-generation learning can benefit as much from understanding
why designs fail as it can from understanding why they succeed.
In the area of settlement distribution, success and failure comprise a
continuum versus a dichotomy. There is typically more success or less
success, or success in some domains and failure in others, rather than
absolute failure. By examining levels of success in two recent settlement
distribution plans, it may be possible to advance our understanding of design
processes sufficiently to avoid modes of failure that might otherwise occur,
and to inform the next generation of settlement plan developers of the
tensions and tradeoffs that may result from features of their plans and their
implementation.
In particular, it is helpful to study the inherent tensions that exist in those
cases. Tensions derive from competing goals. For example, there is a tension
between efficiency and equity in simplifying the claims process for
legitimate claimants and minimizing fraud by requiring comprehensive
documentation. These tensions can pose different issues for different
stakeholders including filers, attorneys, claims administrators, courts, and
regulators. The most critical tension arises over who should have the
decisionmaking authority to resolve or minimize these inherent tensions.
This article is designed to use an examination of two settlement
distribution designs to appreciate some of the second-generation problems
and solutions in this area. In addition, this analytic process should be helpful
in any second-generation evaluation.
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I. INRE CURRENCY CONVERSION FEE ANTITRUST LITIGATION
In 2001, a lawsuit was filed against Mastercard, Visa, Diner's Club, and
their related issuing banks alleging that they had overcharged their customers
from 10%-3% in foreign currency conversion fees in the use of their credit,
charge, debit, and ATM cards between 1996 and 2006.1 The case was settled
in 2006 for $336 million by Mastercard, Visa, Diner's Club, and six issuing
banks. 2 The settlement amount included the administrative fees of the
settlement distribution and attorney's fees.3 As part of the settlement, the
settling banks agreed to insert claim forms for the distribution process in the
monthly paper bills for 20.8 million current MasterCard and Visa accounts
with foreign currency transactions between February 1, 1996 and November
8, 2006.4 On November 8, 2006, the court granted preliminary approval of
the proposed settlement, including the claim form.5 The court also appointed
a claims administrator and made provisions for objections, opportunities to
opt out, and the assessment of attorneys' fees, and set a date for a final
fairness hearing.6
Counsel had developed a claim form and a notice campaign as part of
their settlement agreement. 7 The claim form required that an eligible
cardholder list the annual amount of their foreign transactions for each of
their cards, as indicated in Appendix A. The claims forms were enclosed
with one monthly account statement mailed to cardholders during the period
from January through March of 2007. There was also a website from which a
claim form could be downloaded and a toll free telephone number was made
available for potential beneficiaries with questions.
As of June 30, 2007, there had been 90,000 claim forms filed-60% on
paper and 40% electronically-representing an extremely low response rate
of 0.45% in light of the 20.8 million notices mailed to card holders.8 In
addition, there were complaints filed with the court criticizing the reporting
1 Consolidated Amended Class Action Complaint at 1, In re Currency Conversion
Fee Antitrust Litigation, 265 F. Supp. 2d. 385 (S.D.N.Y. 2003) (Nos. 1409, M 21-95).
2 Stipulation and Agreement of Settlement at 3, In re Currency Conversion Fee
Antitrust Litigation, supra note 1.
3 Id. at 41-42.
4 In re Currency Conversion Antitrust Litigation, Nos. 1409, M 21-95, 2006 WL
3253037 (S.D.N.Y. November 8, 2006) (order certifying settlement classes).
5 Id. at 5.
6Id.
7 Memorandum from Francis E. McGovern, Special Master, to Judge William H.
Pauley III (July 10, 2007) (on file with author).
8 Id. at2.
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requirements in the claiming process and questioning why the data being
requested was not already available to the claims administrator from the
credit card companies. 9 At a hearing on May 11, 2007, the court suggested
the appointment of a special master to assist the court and the parties in
devising and implementing a revised notice and claim procedure. The court
halted the notice campaign and appointed a special master on May 18,
2007.10 After a series of meetings with counsel for the parties, the special
master submitted a report to the court on July 10, 2007 that analyzed the
initial filings, the feasibility of using the banks' data available in a
computerized format, and possible mechanisms for a greater use of that
computerized data in calculating payments, and suggested seven alternative
approaches for structuring the claim filing, review, and payment
mechanisms." Each alternative was presented with accompanying
assumptions and projected outcomes based on six variables: definition of
claimant, size of claimant population, response rate, average payment per
claimant, expected total payment, and expected total cost. 12 The presentation
was made in a format that enabled the court and parties to change the
assumptions about each alternative and readily determine how the outcomes
would be affected by the changes in assumptions.
The special master's report recommended a new notice and claim form
to incorporate three options for claimants to choose from depending on their
estimated losses and ability to thoroughly document their claim: (1) a flat
payment of $25; (2) an estimate of the number of days spent in foreign
countries during the covered time period so an algorithm of typical expenses
would be applied to estimate a payment; and (3) the original form of annual
estimates of foreign expenditures by credit card. The new claim form is
contained in Appendix B. The flat payment option was designed to take
advantage of claimants' propensities to make claims only if the form is easy
to understand and easy to complete, in comparison to having to obtain ten
years of proof of foreign spending. Based upon the forms filed prior to June
30, 2007, it was recommended that an individual who spent no more than one
week abroad or had foreign currency expenditures not greater than $2,500
would have been eligible for a $25 payment that would be consistent with the
limited foreign conversion fees charged to most cardholders. 13 At the same





13 McGovern, supra note 7.
OHIO STATE JOURNAL ON DISPUTE RESOLUTION
cardholders who had foreign currency expenditures were included in the
mailings.
The second option was designed for customers who might feel that $25
was inadequate but that compiling annual records was too onerous or not
feasible. 14 Most foreign travelers can remember how many days they spend
overseas annually more easily than they can remember how much money
they charged on their credit cards. In an optimal world, the issuing banks
would have had a computerized listing of annual charges, but the databases
for those charges were not accessible for a variety of reasons, including
changes in bank ownership of cards, changes in card names, and
incompatibility resulting from changes in databases and their management
software over time. By listing the number of days spent overseas, however, a
claimant would be more likely to feel that the settlement payment would be
based upon their actual circumstances. The calculation of the algorithm could
be accomplished from publicly available data from the travel industry about
foreign expenditures. Although the public travel industry data was not a
perfect fit, assumptions could be made to approximate the annual currency
conversion fees based upon the number of days spent in a foreign country.
The third option was virtually identical to the one offered on the original
claim form. The resulting cover letter and claim form options were reviewed
by the lawyers and the claims administrator, and were further refined based
on testing and feedback obtained from focused interviews with potential
beneficiaries. There was a consensus developed among all the constituents
that the resulting letter, claim form, notice campaign, website, and 800
telephone number scripts were acceptable. 15
On September 17, 2007, the parties submitted a joint status report, and
the court approved the revised claim form package, mailing lists, reduction of
duplicate claims, publication notice program, and revised settlement
distribution schedule.1 6 The parties also included an allocation protocol in the
event that the number and amount of claims exceeded the available funds.
The cost of the mailings, which began on December 1, 2007, to
approximately 38 million cardholders, was anticipated to be approximately
14 The concept of the second option was developed by the special master during a
series of meetings with the parties in order to allow claimants to quantify their foreign
travel in an easier manner than the original claim form afforded.
15 Joint Filing of Proposed Notice Schedule, Claim Form, and Claims and
Administration Budget (S.D.N.Y. August 31, 2007), In re Currency Conversion Fee
Antitrust Litigation, supra note 1; Order (S.D.N.Y. November 24, 2007), In re Currency
Conversion Fee Antitrust Litigation, supra note 1.
16 Joint Filing of Proposed Notice Schedule, Claim Form, and Claims and
Administration Budget, supra note 15.
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$14 million. 17 The revised summary notice contained in Appendix C was
placed in twenty-seven newspapers and other print and electronic media at an
advertising cost of $941,000.
On July 15, 2008, the plaintiffs' counsel filed a status report indicating,
after elimination of duplicates, that there had been 10,115,836 claims filed,
with 7,200,413 claimants choosing option 1; 2,600,315 claimants choosing
option 2; and 315,108 claimants choosing option 3.18 In addition, there were
approximately 22,000 late claims filed, and 2,910 requests for exclusion were
filed.19 Total expenses of claims processing were almost $25,000,000 as of
that time.20
As shown in the table below, an analysis of the claims reveals that 49%
of option 1, 50% of option 2, and 58% of option 3 were filed electronically.
The option 1 claims represent 71.2% of the total claims filed, option 2 claims
represent 25.7%, and option 3 claims represent 3.1%. The overall response
rate greatly increased over the first mailing. The response rate was
approximately 27% of the mailings using the three option claim form. This
rate takes into account that duplicates or suspected duplicates were deducted
from the claims received but remain unknown among the mailings, and a
small percentage of the claims were submitted by downloading the claim
form from the internet site rather than from the mailings. A compilation of
data from other consumer cases in which there have been similar numbers of




Option Claims Filed Electronic Total Filed
1 7,200,413 49 71.2
2 2,600,315 50 25.7
3 315,108 58 3.1
Total 10,115,836 50 100
17 Id. at Tab B.
18 Plaintiffs' Notice of Filing of Status Report Concerning the De-Duping of Claims
and the Settlement Administration Process at 3 (S.D.N.Y. July 15, 2008), In re Currency
Conversion Fee Antitrust Litigation, supra note 1.
19 Id. at4.
2 0 Id. at 13.
21 Analysis of historical case data compiled for presentation to the court in In re
Global Research Analyst Settlement (on file with the author).
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There is no way to know what the response rate would have been if the
original claim form had not been changed. Indeed, most observers would
probably conclude that the extremely low response rate of less than one-half
percent was consistent with other similarly situated cases. What is certain is
that with the addition of new options, as well as a different format and
delivery mechanism, the publication of notice and media coverage around the
case increased the response rate substantially. This increase in access to
claiming among card holders, which could be considered a fairer form of
distribution, was accomplished at significant additional costs and time,
raising one of the inherent tensions between efficiency and equity in the
distribution process.
II. INRE PHARMACEUTICAL INDUSTRY AVERAGE WHOLESALE PRICE
LITIGATION
In 2001, a lawsuit was filed against forty-two pharmaceutical
manufacturers alleging that the defendants reported false and inflated average
wholesale prices (AWP) for certain types of drugs administered through
outpatient clinics.22 AWPs are used to set prescription drug prices for
payment by Medicare, consumers, and insurers.23 The lawsuit sought
damages for overpayments for the affected drugs. In 2006, GlaxoSmithKline
(GSK) settled with the plaintiffs for $70 million.24 After payment of $4.5
million to certain state attorneys general, attorneys' fees, and settlement fund
administrative costs, 70% of the net fund was designated for third-party
payers who made reimbursement payments for one or more of ten named
drugs.25 The remaining 30% was designated for individuals who made
payments or co-payments other than flat or fixed payments. The time frame
varied but was generally from 1991 to 2006.26
After preliminary approval of the settlement on November 15, 2006,
nationwide notice by publication and by website was provided.27 In addition,
22 Complaint, In re Pharmaceutical Industry Average Wholesale Price Litigation,
(D. Mass. 2001) (No. 01-CV-12257-PBS, MDL. No. 1456).
2 3 Id.
24 Settlement Agreement and Release of the GlaxoSmithKline Defendants at 4 (D.
Mass. June 22, 2007), In re Pharmaceutical Industry Average Wholesale Price Litigation,
supra note 22.
25 Id. at 5.
26 Id.
27 Declaration of Katherine Kinsella in Support of Motion for Final Approval of the
Settlement with GlaxoSmithKline at 10 (D. Mass. June 22, 2007), In re Pharmaceutical
Industry Average Wholesale Price Litigation, supra note 22.
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mail notice was sent in January 2007 to 2.5 million individuals who had been
identified by billing codes in Medicare Part B records of the Centers for
Medicare and Medicaid Services as associated with the GSK drugs at issue.28
The notice by mail included an explanation of the settlement, and a claim
form and an opt-out form as contained in Appendix D and Appendix E. The
court appointed a special master on November 15, 2006, to review the
proposed settlement, focusing on the adequacy of the amount of payment to
the consumer class members and the method of distribution to those
consumers.
29
The claim form enabled class members to make a claim for qualified
expenditures for each covered drug during the class period. Proof of payment
included a written prescription, a receipt, a cancelled check or credit card
statement reflecting payment, an explanation of benefits showing an
obligation to pay, a letter from a physician proving an obligation to pay, or a
notarized statement proving payment. See Appendix D. These kinds of
required proof are typical of this type of consumer settlement. The deadline
for filing exclusions was May 27, 2007, and the deadline for filing claims
was May 28, 2007.
By the April through May 2007 period, approximately 10,000 consumer
claim forms had been filed with a preliminarily estimated average value of
about $230, and about 20,000 requests for exclusion, or "opt-outs," were
made.30 The large number of requests for exclusion, relative to the number of
claim forms, led to a request to the court for the special master to delay the
filing of a report until a greater understanding of the nature of these claims
and opt-out requests could be analyzed. On May 21, 2007, the court
approved the special master's request to conduct a survey of consumers who
28 Plaintiffs' Memorandum in Support of Motion for Preliminary Approval of
Settlement Agreement and Release of the GlaxoSmithKline Defendants at Exhibit B (D.
Mass. June 22, 2007), In re Pharmaceutical Industry Average Wholesale Price Litigation,
supra note 22; Order Granting Preliminary Approval of the GlaxoSmithKline Settlement,
Certifying Class for Purposes of Settlement, Directing Notice to the Class and Scheduling
Fairness Hearing at 8 (D. Mass. November 15, 2006), In re Pharmaceutical Industry
Average Wholesale Price Litigation, supra note 22; Final Order and Judgment Granting
Final Approval to Proposed Class Action Settlement with the GlaxoSmithKline
Defendants, Approving Proposed Allocation of Settlement Funds, and Approving Class
Counsel's Application for Attorneys' Fees, Reimbursement of Litigation Expenses, and
Compensation to Class Representatives at 4 (D. Mass. August 17, 2007), In re
Pharmaceutical Industry Average Wholesale Price Litigation, supra note 22.
29 Report of the Special Master to the Court in In re Pharmaceutical Industry
Average Wholesale Price Litigation regarding proposed settlement with Defendant
GlaxoSmithKline (July 16, 2007) (on file with author).30 Id. at6
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filed exclusion forms.31 The theory behind the survey was to analyze the
responses-claim forms and exclusion forms-more carefully in order to
understand the dimensions of the problems. When exclusions exceed claims,
a settlement is suspect.
One thousand five hundred consumers were selected at random from the
consumers who had submitted exclusion forms. Telephone numbers were
located for 1,367 (91%) of those selected for the survey, and a pre-call letter
was mailed to all 1,367 members of the phone survey sample.32 A total of
876 consumers (64% of the telephone survey population) were interviewed
by telephone by a professional call center staff.33 Those who agreed to be
interviewed answered a series of questions designed primarily to determine
(a) whether they were truly class members, as opposed to, for example,
persons who took a relevant GSK drug but had Medigap or other insurance
that covered their co-payments and (b) if they were part of the class, why
they chose to exclude themselves from the settlement.
A significant number of those surveyed did not remember taking any of
the covered drugs, many had insurance that covered their co-payment
obligation, and many had no recollection of a percentage co-payment or full
payment for the drug. Of those surveyed, 15.65% were estimated to be actual
class members based on recalling the covered drugs, being charged for the
drugs, and either having no insurance or having a percentage co-payment. 34
During the course of the phone survey, those determined to be actual
class members were told that they may be able to reconsider their decision to
exclude themselves if they wished to do so, and 18% indicated that they were
interested in filing a claim. This, added to the 16% who said they originally
intended to file a claim when they submitted the exclusion form, totals 34%
of those determined to be class members who said they were interested in
filing a claim form. The estimates derived from the survey were subject to
unobserved sampling and response and measurement error, but nonetheless
provided important insights about the eligibility and intentions of the opt-
outs. In light of these results, new claim forms were mailed to everyone who
had originally filed an exclusion form and might be interested in filing a
31 Order Regarding Survey of Consumers who Filed a Notice of Exclusion from
Settlement at 1 (D. Mass. May 22, 2006), In re Pharmaceutical Industry Average
Wholesale Price Litigation, supra note 22.
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claim form, along with a letter saying that they could revoke their exclusion
request and file a claim form by a new deadline of July 31, 2007. 35
As of July 11, 2007, there were 21,365 consumers who had filed
exclusion forms.36 As noted above, the survey results suggested that 15.65%
of those who submitted exclusion forms were, in fact, members of the class.
This extrapolates to 3,344 actual class members who requested to opt out of
the settlement. In addition, the survey results suggest that some 16% of the
actual class members who sent in an exclusion form did so under the
mistaken view that they were then filing a claim. 37 This could readily occur
because the exclusion form was the first page of the claim form packet after
the instructions, and included an instruction to sign and return the form. If
this 16% is subtracted from the 3,344 total of class member opt-outs, there
would be 535 fewer opt-outs, or a total of 2,809 actual class members
intending to be excluded from the settlement.
An overall opt out rate can be calculated by projecting from the survey
results. The estimated 2,809 exclusions filed by persons who were eligible
class members and who actually intended to opt-out becomes the numerator
needed to form the class member opt-out percentage. The calculation of the
number of total actual class members-the denominator in determining an
opt-out rate-started with the 2.5 million people who received mailed notice
based on the CMS Medicare Part B list of those who took the relevant GSK
drugs. The survey finding that 15.65% of those surveyed were actual class
members may also be applied to the 2.5 million total, which would produce a
result that the universe of actual class members would be 15.65% of 2.5
million, or 391,250 class members. In all probability, however, the universe
of actual class members among the total who were mailed notice would be
substantially less. This is because (a) the CMS list may have included those
who paid for non-GSK drugs and are therefore not GSK class members, and
(b) the survey sample was taken from persons who affirmatively sent in an
exclusion form and therefore were even more likely to be class members than
those who did nothing. Those who did not respond at all with either a claim
form or an exclusion form may have had lower drug name recognition, no
proof of payment, or a high chance of having full insurance coverage for
their co-payment obligation, or they may have been less likely to be class
members for other reasons, compared with those who actually responded in
some way. It would be reasonable, therefore, to predict that the percentage of
actual class members from the 2.5 million total persons who received notice
35 Id. at 7.
36 Id.
37 1d. at8.
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by mail from the CMS list might be as low as half the estimated percentage
of actual class members among those who filed an exclusion form and were
studied in the survey. Given this assumption, a more conservative estimate of
the number of actual Medicare Part B GSK class members might be between
half of 391,250, or 195,625, and 391,250.
The estimated opt-out percentage of actual class members is between
2,809 of 195,625, or 1.4%, and 2,809 of 391,250, or 0.71%. Moreover, the
traditional definition of opt-out is a person who opts out in order to preserve
the right to sue or pursue a lawsuit. 38 In the survey, only 2.53% of the actual
class members who intended to exclude themselves reported this reason for
opting out. Extrapolating from the survey percentage to the number of
estimated opt-outs by actual class members, an estimated 71 of the 2,809 opt-
outs could be seen as traditional opt-outs under this definition. This would
translate into an opt-out rate of between 0.036% and 0.018% among the
estimated number of actual consumer class members.
As of July 2007, there had been 12,705 claims filed.39 Using the
predicted range of 195,625 to 391,250 as the universe of actual consumer
class members, this would translate into a claims-filed rate of between 3%
and 6%. Response rates for consumer class action settlements like this have
historically been low.40 In a sample of 10 cases of over one million class
members per case, the response rate ranged from less than 1% to 11%, with a
mean response rate of 3.4%.41 Opt-out rates in those same cases ranged form
0% to 0.8%.42 The response rate and opt-out rate in this case fall within that
range.
A preliminary estimate of the average claim payment completed in April,
2007, from a random sample of 140 claims forms filed, suggested that the
average claim payment would be $237.43 Assuming this number reflects the
average value of actual claims once they are all tabulated and approved, the
total value of the claims paid out would be $3,014,515, the rough estimate of
the average claims value multiplied by the 12,705 claim forms filed. This
38 Report, supra note 29, at 9.
39 Id.
40 Analyses of historical case data were compiled for presentation to the Court in In
re Global Research Analyst Settlement and for Report of the Special Master to the Court
in In re Pharmaceutical Industry Average Wholesale Price Litigation regarding proposed
settlement with Defendant GlaxoSmithKline (on file with author).
41 Id.
4 2 Id.
43 Report of the Special Master to the Court regarding proposed settlement with
Defendant GlaxoSmithKline at 9 (D. Mass. July 16, 2007), In re Pharmaceutical Industry
Average Wholesale Price Litigation, supra note 22.
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total represents a significant percentage of the total single damages estimate
for consumers made prior to the settlement.
Based upon the projections using the survey estimates, the amount of
money designated in the settlement was adequate to compensate the
consumer class members, and the method of distribution, although not
robust, was consistent with similarly situated settlements. As was the case in
the Currency Conversion Fee settlement, a complicated, difficult-to-
complete claim form does not create the optimal response.44 This situation
was exacerbated in AWP because of the characteristics of potential
beneficiaries involved, including age, severity of illness, and lack of patient
knowledge. Medicare consumers would be expected to be wary of any
communication regarding their health benefits and many would err on the
side of exclusion rather than jeopardize those benefits. The proof
requirements would also be daunting for many potential claimants. Even the
definition of the class itself deterred complete understanding of the rights
involved.
III. INHERENT TENSIONS
These two case studies suggest that inherent in any settlement
distribution process are various tensions that derive from the competing goals
of equity and efficiency. These tensions seem to exist independent of the type
of settlement, the size of the settlement, the number of potential
beneficiaries, or the subject matter of the settlement. It is possible that
characteristics such as the number of years included in the recovery period
and pre-existing data used to define the pool of eligible claimants can
increase or mitigate these tensions. The following list of ten inherent tensions
illustrates the dilemmas facing the design of a settlement distribution
process. 45 The settlement distribution system design process must confront
each of these tensions and include decisions about them, either consciously
or unconsciously. At the same time, it soon becomes apparent that there is a
paucity of data to provide empirical assistance for evaluating the balance
among the variables in tension, thereby hindering the search for optimal
solutions. Most judgments, or lack of judgments, are made in an empirical
vacuum based upon anecdotal evidence and experience.
44 Memorandum from Francis E. McGovern, Special Master, to Judge William H.
Pauley III, supra note 7.
45 These tensions were the subject of presentations at two conferences, one being the
Claims Administrators Conference in February of 2008 in San Francisco, the second,
Distribution of Securities Litigation Settlements: Improving the Process, in September of
2008 in New York City.
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First, one of the most fundamental tensions relates to the ease or burden
of completing a claim form as opposed to the proof requirements necessary
to prevent potential fraud. The more substantiation required to receive
payment from a settlement, the fewer the number of potential beneficiaries
who will file claim forms. At the same time, the easier the claiming process,
the greater the potential for false claims unless the pool of eligibility can be
identified and substantiated, as in MasterCard!Visa. Most claims
administrators engage in audits of claims filed, but there is very little data to
guide the auditing process other than trial and error in a given case. There is
also the increased administrative cost associated with any audit. On the other
hand, the individualized review of claims can become more expensive than
the value of the false claims. The deterrent effect of auditing procedures is
also reduced by the ad hoc nature of the practices employed by the various
claims administrators. When a potential claimant does not know the potential
efficacy of an audit, the incentives for fraud can increase.
A second and related tension arises in the context of the legal sufficiency
of the claim form and the notice of settlement versus the clarity of the
materials for different types of filers. Lawyers need to ensure that all of the
legal requirements of a settlement are presented to the public in language that
has been proven to be substantially adequate, as oftentimes legalese
obviously conflicts with clarity. Lawyers and judges may appreciate the
meaning and importance of the details of a settlement, whereas the general
public may find the language and level of detail off-putting and
incomprehensible. When confronting a settlement notice that rivals the
Federal Register in its density and over-comprehensiveness, it is not
uncommon to find a potential beneficiary unwilling to expend the necessary
effort even to learn that they are, indeed, a potential beneficiary.
46
Notwithstanding the efforts of the Federal Judicial Center to suggest simpler
and more accessible notice, there still remains much that can be done to
satisfy both legal and practical goals of transferring information. Again, the
literature on this tension is less than adequate to provide an empirical basis
for decisionmaking.
Third, the tension between the desire of plaintiffs' lawyers during
settlement negotiations to expand the number of potential beneficiaries in
order to plead the maximum amount of damage potentially attainable in a
lawsuit and the desire of defense lawyers, after settlement, to include the
maximum scope of a release are often in conflict with the realities of those
46 Report of the Special Master to the Court Regarding Proposed Settlement with
Defendant GlaxoSmithKline at 9 (D. Mass. July 16, 2007), In re Pharmaceutical Industry
Average Wholesale Price Litigation, supra note 22.
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actual plaintiffs who suffered the most.47 This tension among potential
claimants who are included in the case to satisfy the needs of the lawyers as
opposed to the claimants who are most likely harmed has the effect of
diluting the payment from a settlement to any given deserving claimant. It is
not uncommon, therefore, to see counsel satisfied with a low claiming rate
because the proportionate payments to each claimant will be higher. The
over-inclusiveness of the class is mediated by the under-inclusiveness of the
claiming rate. This tension can raise expectations as to the number of
potential beneficiaries of the lawsuit while creating an incentive to use a
claims process that ensures that a lower and more realistic number of claims
are actually filed. The plaintiffs for whom the suit is brought may not
actually be the plaintiffs who legitimately should be paid. There are instances
where a court or regulatory body has limited the definition of actual
beneficiaries to a subset that will actually receive compensation in order to
make payments that might otherwise be diluted into triviality.48
A fourth tension has ramifications similar to the over- and under-
inclusiveness problem-the relationship between response rate and
administrative expenses. The technology is available to expand or contract
notice and, most importantly, follow up to encourage claim filings.49 The
more money spent on administrative costs, the less that is typically available
from a fixed fund for distributions to claimants. The more money spent on
outreach, the lower the per claim payment. Hence, the potential for a
perverse incentive: lower the administrative expenses to create the
appearance of a higher payment per claim when the reality is to lower the
number of claims filed because insufficient monies are spent on
administration. There is some data from the Currency Conversion Fee case
and others suggesting trade-offs between cost and filing rates based upon
different types of mailing and advertising mechanisms, but there is much
more that could be done to systematize the evaluation of this tension.50
47 The larger the number of people included in the class, the smaller the payment per
claimant will be. By definition a fund will pay less per claim the more eligible claimants
there are.
48 GLOBAL RESEARCH ANALYST SETTLEMENT DIsTRIBuTION FUND PLAN, APPENDIX
B at 5, available at http://www.globalresearchanalystsettlement.com/fund.pdf.
49 Memorandum from Francis E. McGovern, Distribution Fund Administrator, to
Judge William H. Pauley III, August 7, 2007 (on file with author) (entitled "Report to the
Court on the Progress of the Implementation of the Distribution Fund Plan in the Global
Research Analyst Settlement and on the Approaches to Disburse Remaining Monies from
the Global Research Analyst Settlement Funds").
50 Executive Summary of the Claims Administrators Conference, San Francisco, CA
(February 22, 2008), supra note 45 (on file with author).
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Claims administrators could develop additional data if there were the
incentive to do so.
The issue of an open-ended fund as opposed to a closed-ended fund
raises a similar, fifth conflict. Defendants typically demand a fixed, all-in
amount in a settlement to include administrative expenses and attorneys'
fees. Once the dollar amount of a settlement is fixed, the variables subject to
manipulation become the costs and the number of claimants. The fewer
claimants there are, the lower the cost and the higher the payment per
claimant. Because most cases are settled rather than litigated to establish a
full recovery, there is, almost by definition, not 100 cents on the dollar to be
paid to each beneficiary. A further reduction in per claimant payments
because of a higher claiming incidence can exacerbate the perception of
inadequate individual payments. 51 On the other hand, an open-ended fund
creates major problems of predictability and even the potential for renewed
litigation. If the administrative expenses are paid by defendants on top of a
settlement figure, there is an economic incentive to reduce costs and divide
control over the distribution process. If there is a residual right for the
defendant to benefit from unexpended monies from either a fixed or open-
ended fund, there are similar potential conflicts. The details of each case will
typically provide insight into the relative risk of a failure mode related to the
type of fund. The availability of systematic data in this regard is, however,
limited.52
The mantra in most administrative processes often focuses on speed,
cost, and quality. 53 It may be possible to satisfy two of those three attributes,
but not all three. Thus, the sixth tension, over speed, often emerges when
there is a threshold of administrative accuracy that must be met, yet there are
pressures to expedite the distribution. Typically, the claimants need more
time because the litigation process lags far behind the alleged misconduct.
For example, claimants may face substantial difficulty obtaining minimum
levels of proof of older transactions required to complete their claims. The
lawyers for both plaintiffs and defendants are eager to finalize the process
after a settlement has been completed. Oftentimes there are appeals that can
lengthen finalization. Then there is the pressure on a court to grant a
51 The scenario of a $336 million fund when divided by 90,000 claims will result in
a larger payment per claim than when divided by 10.6 million claims.
52 See generally James D. Cox and Randall S. Thomas, Letting Billions Slip
Through Your Fingers: Empirical Evidence and Legal Implications of the Failure of
Financial Institutions to Participate in Securities Class Action Settlements, 58 STAN. L.
REv. 411 (2005).
53 There are trade-offs between these elements. For example, it may require more
time and cost to produce a higher quality outcome.
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preliminary or final approval before all the data concerning the number of
claims forms filed and verified have been fully compiled. It is not unusual for
decisions regarding the appropriate speed of a distribution plan to be made in
the context of scheduling orders unrelated to the demands of the
distribution. 54
Efforts to be innovative in the distribution process can conflict with the
desire to make the distribution plan appeal-proof, creating a seventh tension.
There are lawyers whose proclivity seems to be to object to settlements.
Regardless of motives, innovation fuels this proclivity because of the absence
of appellate approval of any procedure that has not been used previously.
Judges or lawyers who desire to improve a distribution process run the risk of
prolonging a distribution pending the resolution of any appellate issues
created by differentiation from previous procedures. The tension here is
readily resolvable by the greater interests in speed and certainty that overrule
any experimentation.
An eighth tension occurs in the context of the interests of claimants in
their privacy and the interests of the public in litigation transparency and
distribution accuracy which requires identification in order to eliminate
duplicate filings. There are numerous instances where legitimate
beneficiaries will not make claims if their name might become part of the
public domain. 55 A related concern often occurs when a potential beneficiary
wants to have no connection with a settlement out of fear that other rights or
benefits might be jeopardized. 56 In other instances there are third parties who
may have access to the names of legitimate beneficiaries but who feel unable
to make those names available to a fund administrator because of privacy
concerns. 57 There may also be additional defendants or holders of
subrogation rights who will want access to the names of beneficiaries in
order to advance their own interests. The ultimate arbiter of this tension will
eventually be a court, but by the time a decision is made, the time may have
passed for the claimant to make an individual decision of whether to
participate in a settlement.
Many settlement funds confront the ninth tension of whether funds must
be distributed to individual beneficiaries or can be given to surrogates for
54 Order granting preliminary approval of settlement (S.D.N.Y. November 8, 2006)
In re Currency Conversion Fee Antitrust Litigation, supra note 1.
55 Claimant communications with claims administrators reported to author (on file
with author).
56 Report of the Special Master to the Court (D. Mass. July 16, 2007), In re
Pharmaceutical Industry Average Wholesale Price Litigation, supra note 22.
57 Third party communications with claims administrators' reported to author (on
file with author).
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those beneficiaries, particularly if the beneficiaries have not claimed the full
fund. State attorneys general lawsuits may result in payments to the state
general or other fund.58 Judges may make cy pres awards to organizations or
other entities that have some overlap in the rationale for the creation of the
settlement fund.59 Almost inevitably there will be monies remaining in a
fixed fund from uncashed checks or reserves established for appeals in order
to ensure that all claims are paid their pro rata share. Unless there is a
residual right established in the settlement process, the parties may request
the court to direct the distribution in a particular manner. Recent literature
has been critical of the ease with which some judges determine how to
distribute these monies.60
The tenth tension discussed here involves the decider of these and
various other tensions and the tools available to the decisionmaker for
making the best choices. Historically, defendants have preferred that
plaintiffs' counsel bear the responsibility for the distribution process.
Likewise, courts have usually not intervened in distribution procedures
devised by the plaintiffs themselves. Lawyers for the plaintiffs have normally
turned to claims administrators to perform the distribution. Almost by
definition, the claims administrators are deferential to the lawyers who hired
them and act accordingly. It is difficult for a claims administrator to overrule
plaintiffs' counsel when confronted by one of these tensions. As a result,
most of these tensions are resolved based upon less than transparent
decisionmaking driven by the interests of the decisionmaking entity.
A more ideal situation could exist if the court had the benefit of both the
expertise and allegiance of the claims administrators performing the
distributions. The more available the data about the potential ramifications
of resolving a tension one way or another and the more ex ante rather than ex
post those tensions are resolved, the more transparent the decisionmaking
process can be. And the more considered the expectations of the parties and
the more accountable the implementer, the more likely the design of the
distribution process could approximate a second generation dispute system
design. The courts, the SEC, and other regulators also face tensions around
data requirements which, while useful to the process, require specifications,
costs, and effort to produce.
58 CHARLES GASPARINO, BLOOD ON THE STREET: THE SENSATIONAL INSIDE STORY
OF How WALL STREET ANALYSTS DUPED A GENERATION OF INVESTORS (2005).
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IV. CONCLUSION
Inherent in the design of any dispute system in general, and in particular
any settlement distribution process, are the seeds of second generation design
issues that will inevitably arise. By appreciating, in advance, the varieties of
potential failure modes that may exist, it is possible to set expectations that
can be consistent with the realities that emerge from the decisions made ab
initio. The most critical issue in designing and managing a settlement
distribution is the determination of who will bear the overall responsibility
for the design and management of the distribution process. The optimal
approach seems to be for the court, with the assistance of a neutral claims
administrator, to make the choices among the various tensions inherent in the
management of a settlement. These choices should be made with the benefit
of empirical evidence of the ramifications of those choices and tailored to the
specific details of the settlement at issue. The tasks of all second generation
dispute system designers include a better understanding of tradeoffs to be
made among the inherent tensions, the development of data to educate
decisionmakers regarding the effects of their decisions, and the tailoring of
those decisions to the realities of each case.
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Appendix A
Claim Form
fyou used a Visa- or credlit card or debI/ATM card, or a Diems Club card to make aforeg ransacton
hom Febray 1, 1996 -Novear 8, 20, you may hve Me # to a red of all or p of the related fobegn tsaci
dres. The deadi neo ila a dalr: January 9, 2008
Or ll out thsorm and mail tto Setement A sratr, PO. Box 2W0, Ptad ls, PA 19105
(!) Your name as it appears on your credit or debitATM card(a:
I lt TII' t l t +1 11 t ~11t 1 7p
Fkr AGde Last
Any other name you have used on a credit or debit/ATM card:Li !I~ t I I I I I I ' ] I I I I I ii =
Firs sAta Last
Your current biling address: .
Street Coy State ZipCode
Your Daythie Phone #: (__ _)_ Your email address:
Ust the amout of all foreignsaao made wst your Visa- or M crdid ordeb!tATM card,
or Diem Club card below. Do rot indude daes made wilh agoverweNt age rd, unls the ageny has
auholzed you to do so,
E3 ap cuds 2Lo In 'ftsO 35713f/
Bark.1
O Pesoalse
' pmc d rn~ qdw ft ac=1ount f Is " Wroid
I y do rd have W aur mr e. you may Mv-de ay te l 4 dIgIft of yo
Social S y sAler h md, but y " m d y be edued If no a t4 #,
dae lst 4 l is o SSN r: hem
For unMrort8 card: YouKA mas Ili the Muri rorterral ery with Offre'4doyermWtnot00 latr (orcpteultl all be Ied (Wad acceset
() You do not have to attach bank or credit card statemets to yo claim. But if you need bank or edt card
statements to complete lt daue, and you no loger have them, Ci'ibank, Chase, Dirm Club, Bask OWFlrel
USA. Bank of Amedca, HSBClHousehotd, MBNA and Wasfingtn MutualProvidlan wig give you copies of at least
6 of your old statements for ree, if available etectonkaly. If your card Is forn another hk ontat your ank.
All clas are subject to audlt. Please keep proof o your eWble ansaotm ur your daies has been
pocessed. By su&bm n a daim, you authadze your bak and ft settlement ad ,istraW to provide and share
ftformafi to verity our status or dal. AD Intronattn you provide will be used ordy for that purpose.
(D Mail your copletd form to: SeftleenAdmidstralor, P.O. Box 290, P6l Wa PA 19105
Do rnola/llto ywrbank orc etcard couprry Do not contadthe Court or i. Defe adabe
I swear under penally of per that the afo on I have provded on Ms daih i s e and corect. that is the ordy
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We are writing on behalf of the U.S. District Court because you are eligible to receive a
Courtapproved refund of fees charged to your eligible cards, which are Visa, MasterCard, and/or
Diners Club credit, charge, and/or debit/ATM cards. The fees were based on foreign
transactions, including both purchases and ATM withdrawals, from February 1, 1996 to
November 8, 2006.
Please read the enclosed Notice explaining the proposed $336 million settlement and all of your
options under the settlement. If you choose to request a refund, you may use one of three
Refund Options. Each of these Options will pay a single refund of fees charged for foreign
transactions on ALL of your eligible cards. You may choose only ONE Option from the following:
Refund Option 1: Request an Easy Refund of $25. This Option is recommended if
you traveled outside of the U.S. for less than one week or had
foreign transactions of less than $2,500 using your eligible cards
during the 1996 to 2006 period. (Green Form); OR
Refund Option 2: Request a Total Estimation Refund based on typical spending
during travel and your answers to a few questions about your own
travel outside of the U.S. This Option is recommended if you
traveled outside of the U.S. for more than one week or had foreign
transactions of more than $2,500 using your eligible cards during the
1996 to 2006 period. Refunds will be a maximum of 1% of estimated
foreign transactions. (Blue Form); OR
Refund Option 3: Request a refund based on information that you provide concerning
your Annual Estimated foreign transactions during the 1996 to
2006 period. This Option is recommended if you had extensive
foreign travel or foreign transactions and are willing to provide year-
by-year information. Refunds will be a maximum of 1% to 3% of
foreign transactions. This is the only Option you can use to get a
refund for corporate card use. (Red Form)
Enclosed are three forms, one for each Refund Option. You may also file online at the
Settlement Administrators website www.ccfsettlement.com, using your Refund ID on the top
of this letter.
Please note that if the volume of claims is unexpectedly high, it may be necessary to adjust
refund amounts.
Please disregard any earlier Notices that you may have received. Additional information is
available
online at www.ccfsettlementcom or by telephone at 1-800-945-9890.
Sincerely,
Settlement Administrator
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You can comaplete this form to request the Easy Rerndot 25 or submit your application online atW,.f ement.tom.
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Appendix C
Authorized by the U.S. District Court for the
Southern District ot New York
- Notice of Class Action Settlement -
To: Visa, MasterCard and Diners Club Cardholders
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ADDendix D
Must be lnre Pharmaceutical lWdstr, Average Wholesale Price Litigation noOfficiatUcOy
Postmarked Docket No. 01-CV-12257-PBS, MDL No. 1456 -GSK Settlement
On or Before
May2,2oo7 CONSUMER CLAIM FORM
G S K
I'd Uke a Payment from the GSK Settlement Fund.
If you would like to submit a claim for part of the gettlement Fund, complete this form and mail it to the
address below, along with one proof of payment for each drug (see Section D below). You may be asked for.
more information at a later time.
Your claim must be postmarked on or before May 28 2007.
ft should be mailed to: GSK AWP Litigation Administrator
cdo Complete Claim Solutions, LLC
P.O. Box 24743
West Palm Beach, FL 33416
Section A -Claimant Identification
Please indicate whether you are. claiming on your own behalf as a Class Member or on behalf of someone
else who is a Class Member.
03 I am a Class Member
0 I am an heir of a Class Member and am filing on behalf of the Class Member
f you are an heir filing on behalf of a Class Member, please indicate the Class Member's name and your
relationship to the Class Member in the space provided below:
Section B - Contact Information for the Person Completing this Form
Name
Street Address Apartment
City State Zip Code
13
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Section C - Purchase Information
In the chart below, please provide the total amount paid (not monthly) by the Class Member, or the amount
the Class Member is obligated to pay, for each of the GSK Covered Drugs listed below, during the Class
Period listed at the top of the column. Please place the total amount (not monthly) of the payment under the
olumn that corresponds to the Class to which the Class Member belongs. A Class Member may have
payments in just one of the Classes or both. For the difference between the two Classes, please consult the
Notice. Do not include flat co-payments.
Medicare Part B Class Private Payor Class
Drug Name January 1,. 1991 - January 1,1991 -
January 1, 2005 August 10, 2006
GSK Kytril Injection S $
Category (granisetron HCL)
A Drugs Zofran Injection 1  S
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Section D - Proof of Payment
For each of the drugs for which you have provided a purchase amount in the table in Section C above, you
, nustprovide one (1) proof of payment
Proof of payment may be in the form of any of the following:
(I) a written prescription for the drug;
(2) a receipt, cancelled check, or credit card statement that shows that you or the Class Member
have paid for the drug;
(3) an EOB (explanation of benefits) that shows you or the Class Member made or are obligated
to make a percentage co-payment for the drug;
(4) a letter from your or the Class Member's physician stating that he or she prescribed and that
the Class Member paid or is obligated to pay a percentage co-payment for the drug at least
once and setting forth the amount of the co-payment; or
(5) a notarized statement signed by you or the Class Member indicating you or the Class Member
paid or are obligated to pay a percentage co-payment for the drug between January 1. 1991
through August 10, 2006, including the total of all percentage co-payments for the drug during
that time period.
Section E - Claimant Signature
declare that the information provided here is correct If not submitting this for myself,






DISPUTE SYSTEM DESIGN ISSUES IN MANAGING SETTLEMENTS
Appendix E
Must be Reeived In re Pharmaceutical Industry Average Wholesale Price Litigation
No Later Than Docket No. 01-CV-12257-PBS, MDL No. 1456-GSKSettlement
May27, 2007
CONSUMER EXCLUSION FORM
Only Complete this Form if You DO NOT Want to be Included in Either
or Both of the GSK Settlement Classes
By Completing This Form You Are Excluding Yourself From Either or Both of The GSK
Settlement Classes and You Will Not Be Included in the Proposed Settlement with GSK
and You Will Not Be Able to File a Claim For Part of the Settlement Fund.
Plteae check the box(es) indicating which of the Classcs you wish to exclude yourself front
o Both Classes: (Mediare Co-Payment Class and Private Panr Class)
o] Medicare Co-Payment Class only
O Private Piar Class on4'
I would like to be excluded from the Class(es) indicated above. I understand that by doing soi am excluding
myself from either or both of tie Classes and that as a result I will not be included in the Proposed Settlement
as a member of the Class(es) from which I am excluding myself. I understand that I will not be able to file a
claim for a partof the Settlement Fund as a member of the Class(es) from which I am excluding myself.
Name
Street
City State Zip code
Signature Print
Date
Exclusion must be received no later than May 27, 2007
GSK AWP Litigation Administrator
cio Complete Claim Solutions, LLC
P.O. Box 24743
West Palm Beach, FL 33416
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